Brainomix raises €1.7M Bridge round

17 October 2016· Oxford, United Kingdom· health, medical_imaging, ai, b2b, b2g, pure_software

To further commercialize its proprietary medical imaging software, e-ASPECTS, and expand market penetration in Europe, Latin America and the United States

Stroke care depends on speed, while lung fibrosis care requires early identification and consistent clinical decision-making over time, underscoring the need for hospital technologies that support clinicians at the point of care. With this investment extension, we are well-positioned to enhance customer support across the US and Europe, accelerating the seamless integration of our technology into existing clinical workflows and expanding access to life-saving treatments.

Dr Michalis Papadakis, co-founder and chief executive

Investors

LeadChimera Partners
Also participating
Parkwalk Advisors

About Brainomix

Headquarters
Oxford, United Kingdom
Founded
2010
Team Size
51–200
Sectors
healthmedical_imagingaib2bb2gpure_software

Source: https://www.brainomix.com/brainomix-completes-a-1-5-million-investment-round/